Executive Summary
The June 29, 2026 batch of 50 filings reveals a pronounced wave of strategic diversification and consolidation across Indian sectors, with capital flowing into high-growth areas like AI data centers, renewable energy, and healthcare infrastructure.
Key period-over-period trends show several target companies facing revenue declines (TTSIPL -25.8% YoY, Aequitas Healthcare -5.1% YoY, GPUIL -23.6% YoY), indicating acquirers are betting on turnaround or strategic value rather than current performance. Insider activity is mixed: while some promoters are reducing pledges (NRB Bearings -4.71% release) and making small open-market purchases, others are selling (Jaipan Industries promoter group -1.47% stake). Forward-looking data highlights multiple delayed closures (Zydus/Sterling Biotech, Lakhotia Polyesters/New Nexus, Samvardhana/HRDPL), signaling execution risk in cross-border and complex domestic deals. Capital allocation is tilted toward growth investments via cash reserves (Standard Glass Lining ₹487Cr, StarlinePS ₹160Cr) rather than shareholder returns. The most critical development is the emergence of a new consolidation theme in solar manufacturing (StarlinePS/Celloraa) and AI infrastructure (Standard Glass/GScale), which could reshape competitive dynamics in these nascent sectors.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Sector Consolidation Regulatory Filings digest from June 27, 2026.
Investment Signals (12)
- Standard Glass Lining Technology ↓ (BULLISH)▲
Entry into AI datacenter infrastructure via ₹487Cr phased investment in GScale Energy, funded from cash reserves; manufacturing to begin Nov 2026 with 80% product design finalized
- StarlinePS Enterprises ↓ (BULLISH)▲
₹160Cr investment for 50% stake in Celloraa Energy (1.2 GW solar cell facility with German tech, expandable to 2.4 GW); zero-revenue target but high-growth sector play
- NRB Bearing ↓ (BULLISH)▲
Promoter Harshbeena Sahney Zaveri released 4.71% pledged shares (45.68L shares) in two tranches, reducing encumbered shares from 11.42% to 6.70% — strong governance signal
- Jagsonpal Pharmaceuticals ↓ (BULLISH)▲
₹20.8Cr acquisition of 85% stake in Aequitas Healthcare (₹53Cr FY26 revenue) for entry into hospital segment; closing by July 15, 2026; funded from internal accruals
- Sanstar Limited ↓ (BULLISH)▲
Corn Products Development Inc. (Ingredion) acquired 9% stake via preferential allotment at ₹110/share (₹198Cr total) — global ingredient major's vote of confidence
- Jaipan Industries ↓ (BEARISH)▲
Promoter group sold 80,000 shares (reducing stake from 32.36% to 30.89%) via open market over two days — sustained selling pressure from insiders
- Zydus Lifesciences ↓ (BEARISH)▲
Second extension of Sterling Biotech API acquisition closing to Sep 30, 2026 (original Dec 31, 2024); repeated delays signal execution challenges
- Lakhotia Polyesters ↓ (BEARISH)▲
Dubai acquisition (New Nexus FZ LLC) delayed to Sep 30, 2026 due to regulatory approval delays; cross-border execution risk
- Pine Labs ↓ (BEARISH)▲
Subsidiary SFNPL's turnover declined 4.4% YoY (₹198.4Cr to ₹189.8Cr); ₹25Cr rights issue to meet working capital needs — subsidiary underperformance
- ICRA Limited ↓ (NEUTRAL)▲
Acquired remaining 40% of D2K Technologies for ₹32Cr; D2K revenue declined 5.1% YoY (₹25.05Cr to ₹23.76Cr) though up from ₹18.58Cr in FY24 — mixed trend
- GeeCee Ventures ↓ (NEUTRAL)▲
Invested ₹0.77Cr in GPUIL at ₹99/share; GPUIL swung from ₹746.6Cr profit to ₹149.6Cr loss in FY26 with 3-year revenue decline trend — contrarian bet
- Aster DM Healthcare ↓ (NEUTRAL)▲
Acquired 100% OCRPS in Alfaone Medicals (₹25Cr); associate's turnover declined 5.2% over 3 years (₹621.8L to ₹589.6L) — increasing control in a weak entity
Risk Flags (10)
- Bharat Petroleum/TTSIPL↓ [HIGH RISK]▼
Target's turnover declined 25.8% YoY (₹545.16Cr to ₹404.60Cr) despite ₹85Cr acquisition for 40% stake — acquiring a shrinking business
- GeeCee Ventures/GPUIL↓ [HIGH RISK]▼
Invested in GPUIL at ₹99/share despite 3-year consecutive revenue decline (₹1408.8Cr→₹778.96Cr→₹480.89Cr→₹367.28Cr) and swing to ₹149.6Cr loss — value trap risk
- Zydus Lifesciences/Sterling Biotech↓ [HIGH RISK]▼
Second extension of closing date (now Sep 30, 2026 from original Dec 31, 2024) — 21-month delay raises questions about deal viability
- Samvardhana Motherson/HRDPL↓ [MEDIUM RISK]▼
Acquisition closing delayed from Q1 FY27 to Q4 FY27 — fourth update since June 2025 disclosure, persistent regulatory hurdles
- Lakhotia Polyesters/New Nexus↓ [MEDIUM RISK]▼
Dubai acquisition delayed to Sep 30, 2026 due to regulatory approval delays — cross-border regulatory risk
- Pine Labs/SFNPL↓ [MEDIUM RISK]▼
Subsidiary turnover declined 4.4% YoY; ₹25Cr rights issue needed for working capital — subsidiary may be cash flow negative
- Aster DM Healthcare/Alfaone Medicals↓ [MEDIUM RISK]▼
Associate's turnover declined for 3 consecutive years (FY24: ₹621.8L, FY25: ₹598.2L, FY26: ₹589.6L) — increasing exposure to deteriorating asset
- Hubtown Limited↓ [MEDIUM RISK]▼
Promoter entity acquired 0.33% shares after Edelweiss invoked encumbrance on 1.71M shares — forced sale/pledge stress in promoter group
- Clio Infotech↓ [MEDIUM RISK]▼
₹87Cr investment in Seychelles-based Clio Tech (incorporated March 2026, zero revenue) — high-risk early-stage cross-border investment with no track record
- Multiple SAST Filings (FDC, Syschem, GNA Axles, Neo Infracon, Credent Global) [LOW-MEDIUM RISK]▼
7+ filings under Regulation 29(2) with zero deal details, valuations, or strategic rationale — opacity in substantial acquisitions raises governance concerns
Opportunities (10)
- Standard Glass Lining/GScale Energy↓ (OPPORTUNITY)◆
Entry into AI datacenter infrastructure (₹487Cr phased investment) with manufacturing starting Nov 2026; 80% product design finalized, orders placed for plant machinery — early mover in India's AI hardware supply chain
- StarlinePS Enterprises/Celloraa Energy↓ (OPPORTUNITY)◆
₹160Cr for 50% stake in 1.2 GW solar cell facility (expandable to 2.4 GW) with German technology; zero-revenue target allows low-base growth; beneficiary of India's solar PLI push
- Sanstar Limited/Ingredion↓ (OPPORTUNITY)◆
Global ingredient major acquired 9% at ₹110/share (₹198Cr); signals potential for strategic partnership or eventual control; Sanstar gains global distribution and R&D access
- Jagsonpal Pharmaceuticals/Aequitas Healthcare↓ (OPPORTUNITY)◆
₹20.8Cr for 85% stake in ₹53Cr revenue hospital services company; closing July 15; entry into high-growth hospital segment with established institutional relationships
- Power Grid/Kakinada I Transmission↓ (OPPORTUNITY)◆
₹20.5Cr acquisition of 100% KITL for green hydrogen/ammonia transmission in Andhra Pradesh — early infrastructure play in India's green hydrogen corridor
- ICRA Limited/D2K Technologies↓ (OPPORTUNITY)◆
₹32Cr for remaining 40% of D2K (₹23.76Cr FY26 revenue); full ownership enables integration and cost synergies; D2K revenue grew 28% from FY24 to FY25 before FY26 dip
- Lumax Auto Technologies/LFAE↓ (OPPORTUNITY)◆
Completed acquisition of remaining 15.97% stake, making LFAE wholly owned; FAE continues technical support and brand use — full control with retained expertise
- Arihant Capital Markets↓ (OPPORTUNITY)◆
Received 'no adverse observations' from BSE and 'no objection' from NSE for composite scheme of arrangement involving 5 entities — potential value unlocking through restructuring
- NRB Bearing↓ (OPPORTUNITY)◆
Promoter pledge release of 4.71% shares (45.68L shares) signals improving financial health and reduced margin call risk; only 6.70% of promoter holding now encumbered
- CHPL Industries/Callista Industries↓ (OPPORTUNITY)◆
Non-promoter acquired 8L convertible warrants (6.01% diluted capital) at ₹10/share with 18-month conversion — potential for 3-5x if conversion price is below market
Sector Themes (6)
- Diversification into High-Growth Sectors◆
3 companies (Standard Glass Lining into AI datacenter, StarlinePS into solar manufacturing, ASI Industries into steel) are diversifying from core businesses into high-growth sectors — theme of legacy companies seeking growth via M&A
- Target Revenue Declines Pre-Acquisition◆
5 of 8 acquisitions with disclosed financials show target revenue declines (TTSIPL -25.8%, Aequitas -5.1%, GPUIL -23.6%, D2K -5.1%, Alfaone Medicals -5.2% over 3 years) — acquirers are buying distressed or cyclical bottoms
- Execution Delays in M&A◆
3 of 10 announced deals have delayed closing timelines (Zydus/Sterling Biotech: 21-month delay, Lakhotia/New Nexus: 3-month delay, Samvardhana/HRDPL: 3-quarter delay) — regulatory and CP hurdles are extending deal timelines
- Insider Activity: Pledge Release vs. Selling◆
NRB Bearing's promoter pledge release (4.71%) contrasts with Jaipan Industries' promoter selling (1.47% stake) — divergent insider sentiment within same period
- Cash-Funded Acquisitions◆
4 major acquisitions (Standard Glass ₹487Cr, StarlinePS ₹160Cr, Jagsonpal ₹20.8Cr, Power Grid ₹20.5Cr) are funded from internal accruals/cash reserves — companies are using strong balance sheets rather than debt for growth
- Subsidiary Consolidation Trend◆
3 companies (Lumax Auto, ICRA, Aster DM) are acquiring minority stakes to gain full control of subsidiaries — theme of simplifying corporate structures and capturing full earnings
Watch List (8)
-
Third extension possible if conditions precedent not met by Sep 30, 2026 — watch for further delays or deal termination
-
Manufacturing commencement in Nov 2026 — watch for pre-production milestones and order book updates
-
Closing expected by July 15, 2026 — watch for completion announcement and integration updates
-
Regulatory and shareholder approvals pending for ₹160Cr investment — watch for approval timeline and facility construction progress
-
Scheme must be filed with NCLT within 6 months (by Dec 25, 2026) — watch for NCLT filing and creditor meetings
-
Acquisition expected to complete within 90 days (by Sep 27, 2026) — watch for TTSIPL's Q1 FY27 performance to assess turnaround
-
Regulatory approvals pending for Dubai acquisition — watch for approval status by Sep 30, 2026 deadline
-
Closing now expected in Q4 FY27 (Jan-Mar 2027) — watch for conditions precedent completion updates
Filing Analyses
(50)
29-06-2026
Standard Engineering Technology Limited (SETL) is acquiring a 51% equity stake in GScale Energy Private Limited for ₹190 Crore as part of a larger ₹487 Crore phased investment program, funded entirely from SETL's own cash reserves. The acquisition marks SETL's entry into the AI Datacenter Infrastructure sector, combining its manufacturing capabilities with GScale's 25+ years of datacenter expertise to produce power and cooling equipment locally. While the move addresses a large and fast-growing market, execution risks remain as manufacturing is slated to begin only in November 2026 and the company's core pharmaceutical equipment business faces potential cyclical headwinds.
- · Manufacturing at Gscale Energy is expected to begin in November 2026.
- · Gscale Energy has already placed orders for all major production plant and machinery.
- · Over 80% of product design is finalized, with some prototypes ready.
- · Letters of Award (LOAs) with leading datacenter clients are in final-stage closure.
- · SETL is rated CRISIL A/Positive.
- · The ₹487 Cr programme is entirely self-funded from SETL's internal cash, with no new debt.
- · India's estimated datacenter investment by 2030 is $60 billion, with $36 billion expected to be spent on power and cooling infrastructure.
- · SETL's core pharmaceutical & chemical equipment business remains fully intact and unaffected.
29-06-2026
Bharat Petroleum Corporation Ltd. (BPCL) has signed an agreement on June 29, 2026 to acquire a 40% equity stake in Tiki Tar and Shell India Private Limited (TTSIPL) for a cash consideration of ₹85 Crore. The acquisition aims to capture the rapidly growing market for Value-Added Bitumen (VAB) in India's infrastructure sector. However, TTSIPL's turnover declined sharply from ₹545.16 Crore in FY2025 to ₹404.60 Crore in FY2026, a drop of approximately 25.8%, indicating recent operational challenges.
- · The acquisition is not a related party transaction and does not involve promoter/group companies.
- · DIPAM approval has been obtained for the acquisition.
- · Completion of the acquisition is expected within 90 days.
- · TTSIPL operates in India with export sales to Nepal, Bhutan, and Bangladesh.
- · TTSIPL's product portfolio includes solutions for highways and airport runways.
29-06-2026
Vyomesh M. Shah HUF, a promoter group entity of Hubtown Limited, acquired 472,354 equity shares (0.33% of total voting capital) on June 25, 2026, following the invocation of an encumbrance by Edelweiss Investment Advisors Limited and subsequent part payment of the outstanding loan. Post-acquisition, the promoter group's total holding increased from 32.84% to 33.17%.
- · The encumbrance on 1,711,170 shares held by Vyomesh M. Shah HUF was invoked by Edelweiss Investment Advisors Limited on March 27, 2026.
- · The acquisition was made pursuant to a part payment of the outstanding loan, resulting in 472,354 shares being credited to the demat account of Vyomesh M. Shah HUF.
- · No shares were encumbered by Vyomesh M. Shah HUF before or after the acquisition; other promoter group entities had 7,500,000 shares encumbered (5.28% of total voting capital) both before and after.
29-06-2026
Zydus Lifesciences Limited has further extended the closing date for its acquisition of the API business of Sterling Biotech Limited from June 30, 2026 to September 30, 2026, as SBL is still completing certain conditions precedent. This marks the second extension of the original expected completion date of December 31, 2024, indicating ongoing delays in the transaction.
- · Original expected completion date was December 31, 2024.
- · First extension moved closing date to June 30, 2026.
- · Second extension moves closing date to September 30, 2026.
- · The Business Transfer Agreement was executed on September 17, 2024.
29-06-2026
The promoters (Sellers) of Glittek Granites Ltd. sold their entire 62.99% stake (1,63,51,010 equity shares) to the Acquirers group led by Maheshkumar Jatashankar Thanki & others, via an off-market transaction completed on June 25, 2026. Consequently, the Acquirers along with Rawmin Mining And Industries Private Limited (PAC) became the new Promoter Group from June 26, 2026. The stake sale involved all key selling shareholders including Kosen Ventures Private Limited (49.98% stake) and the Agarwal family.
- · Kosen Ventures Private Limited alone sold 12,975,000 equity shares, representing 49.98% of the Company's capital.
- · The transaction was executed via an off-market transfer under a Share Purchase Agreement dated January 6, 2026.
- · The Open Offer process must be completed by the Acquirers and PAC as part of the overall acquisition.
- · Equity share capital of the Company: 2,59,59,400 fully paid-up equity shares of Rs. 5 each.
29-06-2026
Jagsonpal Pharmaceuticals Ltd has entered into a Share Purchase Agreement to acquire an 85% stake in Aequitas Healthcare Private Limited for a cash consideration of ₹20.8 Crore. The acquisition marks Jagsonpal's strategic entry into the hospital segment, leveraging Aequitas' established institutional relationships. However, Aequitas' revenue declined from ₹56.19 Crore in FY2024-25 to ₹53.31 Crore in FY2025-26, indicating a recent downturn.
- · Aequitas Healthcare was incorporated on September 7, 2017, and is headquartered in Mumbai.
- · The acquisition is expected to be completed by July 15, 2026.
- · The consideration will be funded from Jagsonpal's internal accruals.
- · The acquisition does not fall under related party transactions.
- · No governmental or regulatory approvals are required for the acquisition.
- · Jagsonpal's portfolio focuses on Gynaecology, Orthopaedics, and Dermatology segments.
29-06-2026
Jagsonpal Pharmaceuticals announced the acquisition of an 85% stake in Aequitas Healthcare Private Limited for ₹20.8 crore, funded from internal accruals. The deal marks Jagsonpal's strategic entry into the hospital segment, leveraging Aequitas' strong institutional relationships and FY26 revenues of ₹53 crore. The transaction is expected to close by July 15, 2026, with Aequitas' current directors retaining a 15% stake and continuing to manage the business.
- · Aequitas was founded in 2017 and has a robust business covering all leading hospital chains in India.
- · Jagsonpal has a portfolio of 20+ brands among the Top 5 in their molecule categories, focusing on Gynaecology, Orthopaedics, and Dermatology.
- · The acquisition is expected to be concluded by July 15, 2026, subject to customary closing conditions.
- · J Sagar & Associates acted as legal advisors to Jagsonpal, while Noverra Partners advised Aequitas.
29-06-2026
Promoter Ms. Rita Shaji John acquired 1,000,000 equity shares (4% of capital) of Kings Infra Ventures Ltd. via transmission on June 24, 2026, following the demise of Mr. Shaji Baby John. This increased her holding from 2.7% to 6.8%, making it a substantial but purely ownership-change event with no financial outlay by the acquirer.
- · The acquisition was by transmission (inheritance) and not a market purchase, so no cash consideration was involved.
- · Ms. Rita Shaji John remains a promoter of the company post-acquisition.
- · The company's total equity share capital of 2,45,05,450 shares of ₹10 each remains unchanged.
- · The filing was made voluntarily as a measure of good compliance, as it was not mandatory under the SAST Regulations (note in Part-B).
29-06-2026
Samvardhana Motherson International Limited (SAMIL) announced that the expected closing of its acquisition of a 28.15% stake in HR Dhauliganga Private Limited (HRDPL), a special purpose vehicle of Hinduja Renewables Energy Private Limited, has been delayed. The transaction, previously expected to close by Q1 FY27, is now likely to be completed during Q4 FY27 due to ongoing completion of conditions precedent.
- · The transaction was originally disclosed on June 19, 2025, with subsequent updates on September 26, 2025, December 25, 2025, and March 26, 2026.
- · The acquisition is for captive power generation and consumption under Electricity Laws.
- · The delay is attributed to ongoing completion of conditions precedent.
29-06-2026
Lakhotia Polyesters (India) Limited has announced a delay in the completion of its proposed acquisition of a 100% stake in New Nexus FZ LLC, a Dubai-based entity. The acquisition, previously expected to close by June 30, 2026, is now likely to be completed on or before September 30, 2026, due to delays in receiving regulatory approvals.
- · The acquisition was initially announced on December 12, 2025, and updated on April 01, 2026.
- · The original deadline for completion was June 30, 2026.
- · The delay is attributed to a delay in receipt of regulatory approvals.
29-06-2026
KCP Sugar and Industries Corporation Ltd. disclosed that Sethi Funds Management Private Limited acquired 1,95,000 equity shares (0.17% of total paid-up capital) via open market purchases. The disclosure was made under SEBI (SAST) Regulation 29(2) on June 29, 2026. The acquisition is relatively small in percentage terms and does not trigger a change in control.
- · The acquisition was made from the open market, not through a negotiated deal.
- · The disclosure was filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011.
- · The company's registered office is in Chennai, with factories in Andhra Pradesh and an engineering division in Tamil Nadu.
29-06-2026
GeeCee Ventures Limited acquired 77,500 equity shares of GMR Power and Urban Infra Limited (GPUIL) for ₹0.77 crore (₹76.72 lakh) via open market purchase, increasing its total investment in GPUIL to ₹3.89 crore and its shareholding to 0.05%. GPUIL reported a net loss of ₹149.57 crore in FY 2025-26, a sharp reversal from a profit of ₹746.60 crore in FY 2024-25, while its turnover declined to ₹367.28 crore from ₹480.89 crore year-over-year.
- · GPUIL's turnover has declined for three consecutive years: ₹1408.78 crore (FY 2022-23) → ₹778.96 crore (FY 2023-24) → ₹480.89 crore (FY 2024-25) → ₹367.28 crore (FY 2025-26).
- · GPUIL swung from a profit of ₹746.60 crore in FY 2024-25 to a loss of ₹149.57 crore in FY 2025-26.
- · The acquisition price was ₹99 per share, and the shares are expected to be credited on June 30, 2026.
- · GeeCee Ventures describes the investment as a 'miniscule part' of its investment portfolio.
- · GPUIL has a commissioned energy capacity of ~2,840 MW and ~1,775 MW under development, with operations in India, Nepal, Indonesia, and Dubai.
29-06-2026
Jhaveri Credits & Capital Ltd. allotted 16,16,088 equity shares to shareholders of U R Energy Private Limited pursuant to a Scheme of Amalgamation approved by NCLT Ahmedabad. The allotment increases the company's paid-up share capital from ₹9,48,59,360 to ₹11,10,20,240. The shares will be listed on BSE after requisite approvals.
- · Share exchange ratio is 253:500 (Transferor:Transferee)
- · NCLT Ahmedabad Bench approved the scheme on March 16, 2026
- · Board meeting commenced at 3:00 PM and concluded at 4:30 PM on June 29, 2026
- · Allotted shares rank pari-passu with existing equity shares
29-06-2026
Lumax Auto Technologies Limited has completed the acquisition of the remaining 15.97% equity stake in Lumax FAE Technologies Private Limited (LFAE) from Francisco Albero SAU (FAE), making LFAE a wholly owned subsidiary effective June 29, 2026. FAE will continue to provide technical support to LFAE and has permitted the continued use of the 'FAE' name for a mutually agreed period.
- · The acquisition was completed on June 29, 2026, following an earlier intimation dated May 29, 2026.
- · FAE will continue to provide technical support to LFAE and has permitted the use of 'FAE' in the company name for a mutually agreed period.
29-06-2026
Clio Infotech Ltd. has approved an investment of up to ₹87,00,00,000 (₹87 Crore) to acquire 100% of Clio Tech Limited, a Seychelles-based IT services company incorporated in March 2026. The acquisition is a related party transaction at arm's length, with ₹21,43,28,550 already invested for 22,30,000 shares. The target has no prior turnover as it has not yet commenced commercial operations.
- · Target company Clio Tech Limited was incorporated on March 16, 2026, and is in initial stage with no commercial operations or turnover.
- · The acquisition is a related party transaction, but promoter/promoter group/group companies have no interest in the target.
- · Balance investment to be made in tranches within 12 months, subject to statutory approvals.
- · Board meeting commenced at 5:15 PM and concluded at 5:45 PM on June 29, 2026.
29-06-2026
Arihant Capital Markets Limited (ACML) has received observation letters with 'no adverse observations' from BSE Limited and 'no objection' from NSE Limited for its composite scheme of arrangement involving multiple group entities. The scheme remains subject to regulatory approvals and must be filed with NCLT within six months. No financial figures or period comparisons were disclosed in this filing.
- · Observation letters received on June 25, 2026, from both BSE and NSE.
- · Validity of BSE observation letter is six months from June 25, 2026, within which the scheme must be submitted to NCLT.
- · Scheme involves five companies: AFSL, ACML, AEFSL, AIBSL, and AMMWML.
- · AEFSL is advised to list its securities and commence trading within 60 days of NCLT order.
- · SEBI provided 18 specific observations/comments that must be complied with.
29-06-2026
Power Grid Corporation of India Limited (POWERGRID) has acquired 100% of Kakinada I Transmission Limited (KITL) for an aggregate cash consideration of approximately ₹20.50 Crore, including 10,000 equity shares at par. The acquisition, completed on June 29, 2026, was made under the Tariff Based Competitive Bidding (TBCB) route to establish transmission infrastructure for green hydrogen/ammonia projects in Andhra Pradesh. KITL, incorporated in February 2025, has no prior turnover as it has not yet commenced commercial operations.
- · KITL was incorporated on 20.02.2025 by the Bid Process Coordinator as per the 'Guidelines Encouraging Competition in Development of Transmission Projects' and 'Tariff based Competitive-bidding Guidelines for Transmission Service' notified by Ministry of Power.
- · The project comprises establishment of a new 765/400kV GIS Sub-station along with STATCOM and 765kV transmission line works in the state of Andhra Pradesh.
- · Approvals for Grant of Transmission License and Adoption of Transmission Charges are to be obtained from Central Electricity Regulatory Commission by KITL after the acquisition.
- · The acquisition price is subject to adjustment as per the audited accounts of the Company as on the acquisition date.
29-06-2026
Inventurus Knowledge Solutions Limited's wholly owned subsidiary, IKS Inc, will invest up to USD 15,000,000 in its associate company IKS WWMG MSO LLC, increasing its stake from 48.02% to 63.49%. The investment aims to transform the group from a service provider to a transformation partner in the healthcare sector, enhancing platform stickiness and market position. The target entity, incorporated in June 2025, has generated nil revenue in FY 2025-26, indicating early-stage operations.
- · WWMG MSO was incorporated on June 12, 2025 in the United States.
- · The target entity has no revenue in FY 2025-26 and only $0.08 million in other income.
- · The investment is a related party transaction as it involves a subsidiary investing in its associate.
- · The first tranche of $3,000,000 is due on or before July 3, 2026.
- · The entire investment must be completed on or before March 31, 2029.
- · The Board meeting lasted 19 minutes (06:25 PM to 06:44 PM IST).
29-06-2026
StarlinePS Enterprises Limited has approved a ₹160 Crore investment to acquire a 50% stake in Celloraa Energy Private Limited, a newly incorporated solar cell manufacturer. The target company is establishing a 1.2 GW solar cell manufacturing facility with advanced German technology and plans to expand to 2.4 GW. The acquisition will be completed in cash in one or more tranches within 12 months, subject to regulatory and shareholder approvals.
- · Celloraa Energy Private Limited was incorporated on 06th February, 2026 and has nil turnover for FY2023-24, FY2024-25, and FY2025-26.
- · The acquisition does not fall under related party transactions.
- · The target entity's authorized share capital is ₹1,00,00,000 divided into 10,00,000 equity shares of ₹10 each; paid-up capital is ₹2,50,000 divided into 25,000 equity shares of ₹10 each.
- · The acquisition is expected to be completed within the next 12 months.
29-06-2026
Pine Labs Limited invested INR 24,99,93,297 (₹24,99,93,297) to acquire 49,869 equity shares of its wholly owned subsidiary Synergistic Financial Networks Private Limited (SFNPL) via a rights issue, with no change in shareholding percentage. The investment is aimed at meeting SFNPL's working capital needs and supporting growth in its financial technology business. However, SFNPL's turnover has declined from INR 1,983.9 million in FY2025 to INR 1,897.5 million in FY2026, a drop of approximately 4.4%.
- · The investment is via rights issue, not open market, and represents additional funding for a wholly owned subsidiary.
- · SFNPL was incorporated on March 12, 2008, and operates in the financial technology industry in India.
- · The transaction is not a related party transaction and does not require governmental or regulatory approvals.
- · SFNPL's turnover trend: FY2024 INR 1967.7 million, FY2025 INR 1983.9 million (0.8% increase), FY2026 INR 1897.5 million (4.4% decline).
29-06-2026
Chambal Breweries & Distilleries Ltd (Transferor) will amalgamate into Invade Agro Ltd (Transferee) under a Scheme of Amalgamation approved by the Board on June 29, 2026, with an appointed date of June 1, 2026. The Transferee, which already holds 22.93% of the Transferor's equity, will issue 5 equity shares for every 2 shares held by the Transferor's shareholders. The Transferor has nil turnover and negative net worth of ₹86.68 Lakhs, while the Transferee has a turnover of ₹8,797.35 Lakhs and net worth of ₹30,343.34 Lakhs, highlighting a significant disparity in financial strength.
- · The Transferor Company (Chambal Breweries) has nil turnover and negative net worth of ₹86.68 Lakhs, while the Transferee (Invade Agro) has a turnover of ₹8,797.35 Lakhs and net worth of ₹30,343.34 Lakhs.
- · The appointed date for the amalgamation is June 1, 2026.
- · The exchange ratio is 5 equity shares of Invade Agro (₹10 each) for every 2 equity shares of Chambal Breweries (₹10 each).
- · The Transferee already holds 22.93% of the paid-up equity share capital of the Transferor.
- · The Scheme is subject to approvals from shareholders, creditors, and the National Company Law Tribunal (NCLT).
29-06-2026
Corn Products Development Inc. (Ingredion Incorporated) acquired 1,80,24,157 equity shares of Sanstar Limited via preferential allotment on June 24, 2026, representing 9.00% of the expanded share capital and 9.00% of the fully diluted share capital post-acquisition. The acquisition was made at an issue price of ₹110 per share, aggregating to ₹1,98,26,57,270. This is a significant minority stake acquisition by a global ingredient company.
- · The acquisition was made via preferential allotment under SEBI (ICDR) Regulations, 2018.
- · No outstanding convertible securities or warrants were allotted.
- · The acquirer is not part of the promoter group.
- · The face value of Sanstar Limited equity shares is ₹2 each.
29-06-2026
Aster DM Healthcare Limited acquired 3,57,143 Optionally Convertible Redeemable Preference Shares (OCRPS) in its associate Alfaone Medicals Private Limited for a cash consideration of ₹25,00,00,100 (₹25 Crore and Hundred Only) on June 29, 2026. The acquisition increases Aster's OCRPS holding in AMPL to 100% (37,54,243 shares) while its equity stake remains unchanged at 48.91%. However, AMPL's turnover has declined over the past three years, from ₹621.79 lakh in FY2023-24 to ₹589.55 lakh in FY2025-26, indicating a negative trend.
- · The transaction is classified as a related party transaction and was approved by the Board at arm's length.
- · AMPL was incorporated on December 3, 2020, in Bengaluru, Karnataka, and is engaged in trading drugs and pharmaceuticals.
- · No governmental or regulatory approvals were required for the acquisition.
- · The investment is for general corporate purposes.
29-06-2026
Classic Filaments Limited has completed the acquisition of a 73.75% equity stake in Solven Power Systems Private Limited, making it a subsidiary. The acquisition was executed via a Share Transfer Agreement on June 29, 2026, following an earlier intimation on May 15, 2026. No financial terms or performance metrics were disclosed in this filing.
- · The acquisition was completed via a Share Transfer Agreement on June 29, 2026.
- · Solven Power Systems Private Limited has become a subsidiary of Classic Filaments Limited.
- · The company had previously intimated the proposed acquisition on May 15, 2026.
29-06-2026
The filing discloses a transaction under SEBI (SAST) Regulations, 2011, involving Varigate Advisory Services (P) Ltd and Sanjay Otawat as acquirers of shares in Arman Holdings Limited. No financial terms, valuation, strategic rationale, or quantitative data are provided in the disclosure. The filing is purely regulatory with no deal structure, pricing, or impact details.
- · Filing is under Regulation 29(2) of SEBI SAST Regulations, which mandates disclosure by acquirers crossing certain thresholds or having made a public announcement, though details of the trigger event are not provided.
- · No mention of the number of shares acquired, the price, the stake percentage, or whether the acquisition is open market, preferential, or via a takeover offer.
- · Acquirers are Varigate Advisory Services (P) Ltd and an individual, Sanjay Otawat.
- · The company is Arman Holdings Limited, listed on BSE (Scrip ID: 538556).
29-06-2026
Alkem Laboratories Limited, through its wholly owned subsidiary Alkem Medtech Private Limited, is proceeding with the acquisition of a controlling stake (51% to 55%) in Swiss company Occlutech Holding AG. On June 26, 2026, Alkem Medtech executed a First Supplementary Agreement to the original Share Purchase Agreement dated March 6, 2026, with the selling shareholders of Occlutech. This filing updates the stock exchanges on the progress of the acquisition, following earlier intimations in February and March 2026.
- · The First Supplementary Agreement was executed on June 26, 2026.
- · The acquisition is structured through a wholly owned subsidiary, Alkem Medtech Private Limited.
- · The target company, Occlutech Holding AG, is incorporated in Switzerland.
- · This filing follows prior intimations dated February 13, 2026 and March 6, 2026.
29-06-2026
The filing announces the acquisition of Zee Media Corporation Limited by Magnifica Global Opportunities Fund – MGO High Conviction. The acquirer holds 18000 Crore (₹18000 Cr) in shares and has secured regulatory approvals. No financial terms of the transaction were disclosed in the available text.
- · Acquirer: Magnifica Global Opportunities Fund – MGO High Conviction
- · Target: Zee Media Corporation Limited
- · Filing date: June 29, 2026
- · Regulatory approvals have been secured for the acquisition.
29-06-2026
Harshbeena Sahney Zaveri, a promoter of NRB Bearings Limited, released 45,68,427 pledged equity shares (4.71% of total share capital) on June 23 and June 25, 2026. This reduced the promoter's encumbered shares from 11.42% to 6.70% of total capital, while total promoter holding remained unchanged at 41.48%. The release of pledge is a positive signal for corporate governance and reduces risk for shareholders.
- · The release was done in two tranches: 37,84,427 shares on June 23, 2026 and 7,84,000 shares on June 25, 2026.
- · Total promoter holding (including encumbered shares) remained unchanged at 4,02,07,885 shares (41.48% of total capital).
- · The filing is made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
29-06-2026
The filing is a disclosure under SEBI (SAST) Regulation 29(2) for FDC Limited, regarding an acquisition of shares by Nandan Mohan Chandavarkar and Persons Acting in Concert (PACs). The disclosure does not specify whether the transaction is a merger, acquisition, or demerger—it is strictly a disclosure of substantial acquisition under the Takeover Code. No deal value, valuation metrics, or financial details are provided in the filing, making it purely a regulatory compliance update. The sector is listed as technology, but FDC Limited is primarily a pharmaceutical company, which may be a data inconsistency.
- · The filing is made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- · The acquirer is Nandan Mohan Chandavarkar along with Persons Acting in Concert (PACs).
- · The target company is FDC Limited (BSE Scrip Code: 531599).
- · No specific number of shares acquired, acquisition price, or percentage of shareholding change has been disclosed in the filing.
- · The sector mentioned in the filing is 'technology', which may be an error as FDC Limited is primarily a pharmaceutical company.
29-06-2026
Bacil Pharma Ltd. has disclosed a filing under SEBI (SAST) Regulations, 2011, Regulation 29(1), regarding Niraj Rajnikant Shah. The filing is a disclosure of acquisition of shares or voting rights, but no specific deal structure, valuation, or strategic rationale is provided. The sector is listed as technology, but the company name suggests a pharmaceutical background, creating ambiguity. No quantitative data, financial metrics, or scheduled events are mentioned in the filing.
29-06-2026
The filing discloses a disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 for Bhavanam Ruthvik Reddy & Dr. Bhaskar Rao Bollineni regarding Crescentis Capital Ltd. The event is a disclosure of substantial acquisition of shares/takeovers, but no specific deal structure, valuation, or financial terms are provided. The sector is listed as technology, but the company name (Crescentis Capital Ltd) suggests a financial services entity, creating a sector mismatch. No quantitative data, financial metrics, or scheduled events are mentioned in the filing.
- · The filing is a disclosure under Regulation 29(2) of SEBI SAST Regulations, indicating a substantial acquisition of shares or voting rights in Crescentis Capital Ltd.
- · The acquirers are individuals: Bhavanam Ruthvik Reddy and Dr. Bhaskar Rao Bollineni.
- · The sector is listed as 'technology' but the target company name (Crescentis Capital Ltd) suggests a financial services entity, creating a potential sector mismatch.
- · No deal size, share count, percentage changes, or financial metrics are disclosed in the filing.
29-06-2026
ASI Industries Limited has incorporated a wholly-owned subsidiary, ASI Steel & Energy Limited, on June 26, 2026, with an initial investment of up to ₹7,50,000 (Rupees Seven Lakh Fifty Thousand Only). The subsidiary is established to explore opportunities in the iron and steel industry, specifically for setting up a TMT steel plant, as the company sees limited expansion potential in its existing main business of mining and processing Kotah Stone. ASI Industries holds 75% equity in the subsidiary, while promoters/promoter group hold the remaining 25%.
- · The subsidiary was incorporated in Mumbai, Maharashtra.
- · The Certificate of Incorporation was uploaded on the MCA portal on June 26, 2026 at 19:03 hours IST, outside normal working hours, hence the disclosure was made on the next working day.
- · The subsidiary is yet to commence business operations; turnover and history are not applicable.
- · No governmental or regulatory approvals were required for the acquisition.
- · The consideration was in the form of cash subscription to share capital.
29-06-2026
This filing is a disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011, by Syschem (India) Ltd. concerning Ruchika Jain. The event is a substantial acquisition of shares disclosure. The filing contains no financial metrics, deal valuation, or operational details, making it purely a regulatory update.
- · The disclosure is filed under SAST Regulation 29(2) which typically applies to any acquisition of shares or voting rights exceeding 5% or 10% thresholds, or when a person (along with PAC) holds 25% or more voting rights and acquires additional shares beyond the creeping acquisition limit.
- · No details on the exact number of shares acquired, percentage stake change, or whether an open offer was triggered are provided in this summary.
- · Ruchika Jain is the disclosed acquirer – relationship to the company (existing promoter/unrelated investor) is NOT_DISCLOSED.
29-06-2026
The filing is a disclosure under SEBI (SAST) Regulations, 2011, specifically Regulation 29(2), regarding Rima Arora. No financial details, deal structure, valuation, or strategic rationale are provided in the filing. The disclosure is purely procedural and does not contain any quantitative data or forward-looking statements.
29-06-2026
Promoter group entities of NCL Industries Limited—Kalidindi Ravi, Kakatiya Industries Private Ltd, and Vikram Chemicals Private Ltd—acquired a total of 7,700 equity shares via open market on June 25, 2026. The acquisitions were marginal, increasing the promoters' collective stake from 8.36% to 8.39%, with no material change in control or ownership structure.
- · Acquisition date: June 25, 2026
- · Kalidindi Ravi acquired 1,000 shares, increasing his holding from 6.99% to 7.00%
- · Kakatiya Industries Private Ltd acquired 3,000 shares, increasing its holding from 1.37% to 1.38%
- · Vikram Chemicals Private Ltd acquired 3,700 shares, increasing its holding from 0.00% to 0.01%
- · No shares were encumbered (pledged) before or after the acquisition
- · The company's equity share capital remained unchanged at ₹45,23,27,900
29-06-2026
Kumar Agrawal, a member of the promoter group of Godawari Power and Ispat Limited (GPIL), acquired 1,50,000 equity shares (0.02% of total share capital) via transmission from Late Mrs. Madhu Agrawal on June 23, 2026. The transaction is exempt from open offer requirements under SEBI SAST Regulations (Regulation 10(1)(g) – transmission/succession). The consolidated promoter and promoter group shareholding remained unchanged at 63.18% post-transmission, as the shares were transferred within the group.
- · The transmission occurred on June 23, 2026, and the disclosure was filed on June 26, 2026.
- · The exemption is under Regulation 10(1)(g) of SEBI SAST Regulations (transmission, succession, or inheritance).
- · Kumar Agrawal's individual shareholding increased from 22,191,055 shares (3.30%) to 22,341,055 shares (3.32%).
- · Late Mrs. Madhu Agrawal's shareholding decreased from 20,061,155 shares (2.98%) to 19,911,155 shares (2.96%) post-transmission.
- · No change in total promoter group shareholding (63.18%) or total share capital (67,307,430 equity shares).
29-06-2026
Kiran Aggarwal, a promoter of SPL Industries Limited, transferred 8,07,784 equity shares (2.79% of paid-up capital) by way of gift to another promoter on June 25, 2026, under an inter se transfer. As a result, her shareholding decreased from 22.87% to 20.08% of the company's paid-up capital.
- · The transfer was an off-market inter se transfer among promoters by way of gift, with no consideration involved.
- · The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- · After the transfer, the promoter's total shareholding (including shares carrying voting rights) stands at 58,23,609 shares, representing 20.08% of the diluted capital.
29-06-2026
Promoter Krishan Kumar Aggarwal disclosed a 2.60% decrease in his shareholding to 33.99% following the conversion of 6,00,000 warrants into equity shares on June 25, 2026. While the promoter group's total voting rights decreased from 50.85% to 49.65% on a diluted basis, the company's equity capital increased from ₹4,00,00,000 to ₹4,60,00,000 due to the allotment.
- · The promoter group's total diluted shareholding decreased from 50.85% to 49.65%.
- · Krishan Kumar Aggarwal's individual holding increased from 14,63,581 shares (36.59%) to 15,63,581 shares (33.99%) due to the increase in total equity capital.
- · Aayush Aggarwal acquired 50,000 shares, increasing his holding from 0 to 1.09%.
- · Post-acquisition, Krishan Kumar Aggarwal still holds 5,00,000 warrants, and Nitin Aggarwal holds 5,00,000 warrants.
29-06-2026
ICRA Analytics Limited, a material subsidiary of ICRA Limited, has approved the acquisition of the remaining 40% equity stake in D2K Technologies India Private Limited for a cash consideration of INR 32 crore, making D2K a wholly owned step-down subsidiary. D2K reported a turnover of INR 23.76 crore for FY26, down from INR 25.05 crore in FY25, though up from INR 18.58 crore in FY24. The acquisition is subject to successful execution by the depositories.
- · D2K was incorporated on May 4, 2001 and is headquartered in Mumbai, Maharashtra.
- · The acquisition is a related party transaction as D2K is an indirect subsidiary of ICRA Limited (ICRA already held 60% through ICRA Analytics).
- · No governmental or regulatory approval is required for the acquisition.
- · The acquisition is contingent upon successful execution by the depositories.
- · The equity shares acquired have a face value of INR 10 each.
29-06-2026
GNA Axles Limited has filed a disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011, regarding Maninder Singh. The filing is a regulatory disclosure of an acquisition of shares or voting rights, but no specific deal structure, valuation, or strategic rationale details are provided. The sector is listed as technology, which may be a mismatch with GNA Axles' core business (auto components).
- · The filing is a disclosure under Regulation 29(2) of SEBI SAST Regulations, which typically applies when an acquirer crosses certain shareholding thresholds (e.g., 5%, 10%, 14%, etc.) or acquires control.
- · The sector is listed as 'technology', which appears inconsistent with GNA Axles' primary business of automotive axles and components.
- · No details on the number of shares acquired, price, or resulting shareholding percentage are provided in the summary.
29-06-2026
Shudh Edible Products Private Limited, a promoter group company of Dhampur Bio Organics Limited, acquired 18,000 equity shares (0.03% of total voting capital) via open market purchase on June 25, 2026. Post-acquisition, the promoter group's holding increased marginally from 16.90% to 16.93%.
- · The acquisition was made in the open market on June 25, 2026.
- · The total equity share capital of the target company is 6,63,87,590 equity shares of ₹10 each.
- · No shares were encumbered before or after the acquisition.
29-06-2026
V.S.T Tillers Tractors Limited disclosed that Mr. V.V. Pravindra, a promoter group member, continues to hold 2,24,146 shares (2.59% of total share capital) following the deletion of Mr. V.K. Surendra as a joint holder due to his demise. There is no change in the actual shareholding or voting rights of the acquirer.
- · The event is reported under SEBI Takeover Regulations due to the deletion of a joint holder's name following death, not due to any acquisition or sale.
- · No shares were acquired or sold; the holding remains unchanged at 2,24,146 shares (2.59%).
- · Total equity share capital of the company is 8,65,27,540 shares.
29-06-2026
The filing is a disclosure under SEBI (SAST) Regulations, 2011, specifically Regulation 29(2), regarding NM Merchantiles Ltd's acquisition of shares in IOL Chemicals and Pharmaceuticals Limited. The filing does not provide any financial details, deal valuation, strategic rationale, or shareholding changes. It is purely a regulatory disclosure with no quantitative data on transaction size, swap ratio, or financial impact. The absence of material financial or operational metrics limits the ability to assess the deal's significance or impact on shareholders.
29-06-2026
DESAI SHARES AND STOCK PRIVATE LIMITED, a promoter group entity, acquired 1,356 equity shares of Bharat Parenterals Limited through open market purchases between June 1-25, 2026. Post-acquisition, its holding increased from 39.65% to 39.67% of the total voting capital.
- · Acquisition was made in the open market between June 1, 2026 and June 25, 2026.
- · The acquirer is part of the promoter group.
- · No shares were encumbered before or after the acquisition.
- · The total diluted share capital remains unchanged at 68,91,963 shares.
29-06-2026
Promoter group of Lyka Labs Limited, led by Mr. Kunal Gandhi, acquired an additional 55,967 equity shares (0.15% of voting capital) via open market purchases on June 24-25, 2026. Post-acquisition, the promoter group's total holding increased from 16.03% to 16.19%, a marginal increase of 0.16 percentage points. The acquisition is small in scale and does not trigger any change in control or material shift in ownership.
- · The acquisition was executed via open market purchases on two consecutive days: June 24 and June 25, 2026.
- · No shares were acquired under encumbrance (pledge/lien) or through convertible instruments.
- · The total diluted share capital of the company remains unchanged at 3,56,90,000 equity shares.
- · The filing is made under Regulation 29(2) of SEBI (SAST) Regulations, 2011, which requires disclosure for any acquisition exceeding 5% but below 25% of voting rights.
29-06-2026
Manisha Vikaskumar Saraf, a non-promoter shareholder, acquired 8,00,000 convertible warrants of Callista Industries Ltd (face value ₹10 each) via preferential allotment on June 25, 2026, increasing her total warrant holdings from 10,00,000 to 18,00,000 (from 3.33% to 6.01% of diluted capital). The warrants are convertible into equity shares at a 1:1 ratio within 18 months at ₹10 per share, with no redemption feature. This acquisition does not involve voting rights until conversion, and the company's equity capital increased from ₹5,79,65,880 to ₹6,04,65,880 post-allotment.
- · Warrants are convertible into equity shares within 18 months from allotment date at a 1:1 ratio and a conversion price of ₹10 per share.
- · No redemption feature; warrants either convert into equity or lapse.
- · The acquirer is not part of the promoter group.
- · The acquisition was made via preferential allotment, not open market purchase.
29-06-2026
This is a disclosure filing under SEBI (SAST) Regulations, 2011 by Neo Infracon Ltd. The filing contains no details on the deal structure, rationale, valuation, or financial impact—it is purely a procedural disclosure regarding the acquisition of shares/pie by Darshik D Mehta. No positive or negative metrics are reported; the filing is purely informational without quantifiable business or financial data.
29-06-2026
Atin J. Agarwal sold 80,000 equity shares of Jaipan Industries Ltd (target company) on the open market from June 15 to June 16, 2026, reducing his holding from 2,72,665 shares (4.98%) to 1,92,665 shares (3.52%). The sellers include Jainarain O Agarwal, Veena Jainarain Agarwal, Atin J. Agarwal, Neha Jainarayan Agarwal, and Shirish D. Gotech, who are part of the promoter group. Post-sale, the promoter group's total holding decreased from 17,68,166 shares (32.36%) to 16,88,166 shares (30.89%).
- · Sale executed on open market from June 15 to June 16, 2026.
- · Pre-sale promoter group held 17,68,166 shares (32.36% voting rights); post-sale holds 16,88,166 shares (30.89%).
- · Atin J. Agarwal sold 80,000 shares, reducing his holding from 2,72,665 (4.98%) to 1,92,665 (3.52%).
- · Other promoter group members (Jainarain O Agarwal, Veena Jainarain Agarwal, Neha Jainarayan Agarwal, Shirish D. Gotech) did not change their holdings.
- · Target company's equity share capital: ₹9,08,88,73,200 / 90,88,87,320 equity shares of ₹10 each.
29-06-2026
Beryl Drugs Ltd. filed a disclosure under SEBI (SAST) Regulations, 2011, Regulation 29(1), regarding Sudhir Sethi. The filing is a procedural disclosure of an acquisition event, but no specific deal structure, valuation, or strategic rationale is provided. The filing lacks quantitative details such as transaction value, share count, or financial metrics, making it purely informational with no actionable investment signal.
29-06-2026
Credent Global Finance Ltd filed a disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011, indicating a substantial acquisition of shares by DP Global Wealth Management LLP and Vikas Kataria. The filing provides no financial details, deal valuation, or strategic rationale, limiting analysis to regulatory compliance only. No positive or negative performance metrics are disclosed.
- · Filing is under Regulation 29(2) of SEBI SAST, which requires disclosure when an acquirer holds shares/voting rights exceeding 5%, 10%, 14%, 54%, 74%, or 90% thresholds, or upon crossing 25% in a financial year.
- · No specific share count, percentage acquired, or consideration amount is disclosed in the filing summary.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Sector Consolidation Regulatory Filings
June 26, 2026
India Sector Consolidation Regulatory Filings — June 26, 2026
June 25, 2026
India Sector Consolidation Regulatory Filings — June 25, 2026
June 24, 2026
India Sector Consolidation Regulatory Filings — June 24, 2026
June 23, 2026
India Sector Consolidation Regulatory Filings — June 23, 2026
🇮🇳 More from India
View all →June 29, 2026
India Pre-Market Regulatory Roundup — June 29, 2026
India Pre-Market Regulatory Roundup
June 29, 2026
India Quarterly Results BSE NSE Announcements — June 29, 2026
India Quarterly Results BSE NSE Announcements
June 29, 2026
India Upcoming Corporate Actions BSE NSE — June 29, 2026
India Upcoming Corporate Actions BSE NSE
June 29, 2026
BSE Sensex 30 Stocks Regulatory Filings — June 29, 2026
BSE Sensex 30 Stocks Regulatory Filings